BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 87 filers reported holding BICYCLE THERAPEUTICS PLC in Q4 2022. The put-call ratio across all filers is 3.51 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $232,803 | -35.8% | 11,588 | -18.5% | 0.49% | -13.2% |
| Q2 2023 | $362,869 | +12.5% | 14,219 | -6.3% | 0.56% | +19.3% |
| Q1 2023 | $322,645 | -36.1% | 15,169 | -11.1% | 0.47% | -26.9% |
| Q4 2022 | $505,183 | +0.6% | 17,067 | -21.0% | 0.64% | +30.6% |
| Q3 2022 | $502,000 | +30.1% | 21,594 | -6.2% | 0.49% | +38.9% |
| Q2 2022 | $386,000 | -47.1% | 23,019 | +38.5% | 0.36% | -10.6% |
| Q1 2022 | $730,000 | – | 16,625 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 917,218 | $40,248,000 | 48.61% |
| GREAT POINT PARTNERS LLC | 550,592 | $24,160,000 | 5.84% |
| Logos Global Management LP | 950,000 | $41,686,000 | 5.40% |
| Deep Track Capital, LP | 1,855,993 | $81,441,000 | 5.22% |
| First Light Asset Management, LLC | 890,174 | $39,061,000 | 3.44% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,154,126 | $50,643,000 | 3.00% |
| Ikarian Capital, LLC | 478,784 | $21,009,000 | 2.76% |
| Opaleye Management Inc. | 175,000 | $7,679,000 | 2.38% |
| Frazier Life Sciences Management, L.P. | 603,521 | $26,483,000 | 2.26% |
| Altium Capital Management LP | 120,000 | $5,266,000 | 1.76% |